Results 261 to 270 of about 3,181,850 (358)

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli, Mudasir Andrabi, Tova Cohen, Pranali G. Patel, Tapasya Katta, Chen Lin   +5 more
wiley   +1 more source

Evidence-Based Monitoring of Prodiplosis longifila in Foliage Crops: Damage, Economic Impact, Trapping Tools, and Population Dynamics. [PDF]

Neotrop Entomol
Naranjo-Serrato AN, Cardenas-Urrego WF, Villamil-Martha HJ, Pardo-Ramirez LM, Ramirez-Gil JG.   +4 more
europepmc   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane, Giorgia Coratti, Chiara Cutrì, Antonio Varone, Riccardo Masson, Adele D'Amico, Valeria Sansone, Sonia Messina, Federica Ricci, Chiara Ticci, Claudio Bruno, Caterina Agosto, Francesca Benedetti, Antonella Pini, Sabrina Siliquini, Massimiliano Filosto, Alberto Zambon, Ilaria Bitetti, Maria Rosaria Manna, Claudia Dosi, Riccardo Zanin, Stefano Parravicini, Roberto De Sanctis, Giulia Stanca, Michela Catteruccia, Michele Tosi, Irene Mizzoni, Emilio Albamonte, Valentina Franchino, Maria Sframeli, Ilaria Cavallina, Elena Procopio, Michele Sacchini, Simone Morando, Noemi Brolatti, Federica Trucco, Gaia Scarpini, Elena Briganti, Beatrice Berti, Concetta Palermo, Daniela Leone, Stefano C. Previtali, Eugenio Mercuri, the ITASMAC working group   +43 more
wiley   +1 more source

Global maternal and infant health monitoring systems: a scoping review protocol. [PDF]

BMJ Open
Al-Habbal K, Hassan Z, Kaddoura R, Yousef S, Fetty J.   +4 more
europepmc   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

Prioritising Indicators for Large-scale Monitoring and Assessment of Food Environments for Public Health. [PDF]

Curr Obes Rep
Vanderlee L, Garton K, Ahmed M, Backholer K, Batis C, Bragg MA, Boyland E, Cameron AJ, Castronuovo L, Dunford EK, Gómez-Donoso C, Hu G, Jones A, Kelly B, Laar A, Lewis M, Méndez-Lazarte C, Mackay S, Pollard CM, Reeve E, Schultz S, Scapin T, Soares-Wynter S, Swart R, Swinburn B, Vaillancourt C, Sacks G.   +26 more
europepmc   +1 more source

Daily microhabitat shifting of solitarious-phase Desert locust adults: implications for meaningful population monitoring. [PDF]

Springerplus, 2016
Maeno KO, Ould Ely S, Nakamura S, Abdellaoui K, Cissé S, Jaavar Mel H, Ould Mohamed S, Atheimine M, Ould Babah MA.   +8 more
europepmc   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao, Rong Li, Yu‐Xiang Jiao, Kai Ma, Hong‐Qi Yang, Zheng‐Yu Sun, Jie‐Wen Zhang, Shuai Chen   +7 more
wiley   +1 more source

WHO launches global network of institutes to strengthen capacity for health inequality monitoring. [PDF]

Int J Equity Health
Health Inequality Monitoring Network.
europepmc   +1 more source

SAS score: Targeting high-specificity for efficient population-wide monitoring of obstructive sleep apnea

, 2018
Alexandru Topîrceanu, Mihai Udrescu, Lucreția Udrescu, Carmen Ardelean, Rodica Dan, Daniela Reisz, Ștefan Mihăicuță   +6 more
openalex   +2 more sources